Ticagrelor and Eptifibatide Bolus-Only Versus Ticagrelor and Eptifibatide Bolus Plus Abbreviated Infusion
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
This purpose of this study is to measure platelet response to ticagrelor and eptifibatide
bolus-only compared with ticagrelor and eptifibatide bolus plus 2-hour infusion administrated
after cardiac catheterization in patients undergoing non-emergent percutaneous coronary
intervention.